Fabiola Aguilar-Marin
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Blockade of the NLRP3 inflammasome improves metabolic health and lifespan in obese mice.
Journal: GeroScience
Published: August 30, 2019
NLRP3 Inflammasome Inhibition by MCC950 in Aged Mice Improves Health via Enhanced Autophagy and PPARα Activity.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: March 14, 2019
NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice.
Journal: Aging cell
Published: March 01, 2019
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns.
Journal: Pharmacological research
Published: February 19, 2018
Adenosine Monophosphate (AMP)-Activated Protein Kinase: A New Target for Nutraceutical Compounds.
Journal: International journal of molecular sciences
Published: November 17, 2016
AMPK/Mitochondria in Metabolic Diseases.
Journal: Experientia supplementum (2012)
Published: November 05, 2016
Mutation in cytochrome b gene of mitochondrial DNA in a family with fibromyalgia is associated with NLRP3-inflammasome activation.
Journal: Journal of medical genetics
Published: July 15, 2015
AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.
Journal: Antioxidants & redox signaling
Published: July 02, 2015
Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome.
Journal: Molecular neurobiology
Published: May 18, 2015
Metformin and caloric restriction induce an AMPK-dependent restoration of mitochondrial dysfunction in fibroblasts from Fibromyalgia patients.
Journal: Biochimica et biophysica acta
Published: December 20, 2014
Last Updated: 09/26/2026